Disposable Ureteroscope Market Size, Share | Report 2022-2030
The global disposable ureteroscope market size was estimated at around USD 241.8 million in 2021 and it is projected to hit around USD 1.1586 billion by 2030, growing at a CAGR of 19.02% from 2022 to 2030.
Report Highlights
The major factor attributing to the revenue growth is the growing adoption of disposable ureteroscope for minimally invasive surgeries as they are more economically viable, safer, and reduce hospital stays.
Rising prevalence of chronic kidney diseases due to changes in lifestyle such as reduction in consumption of water, higher intake of alcoholic beverages, and lower physical activities has led to a rise in the conditions requiring such devices for diagnosis and treatment, thereby boosting growth. In addition, an increasing percentage of the obese population also positively impacts revenue growth as they have higher chances of developing kidney stones.
The past few years have witnessed huge improvements in terms of technology and clinical applications. The key participants in the industry are introducing various strategic initiatives to expand their business footprint and gain a competitive edge in the market. Furthermore, the introduction of single-use digital flexible ureteroscope has opened new opportunities for the market. For instance, in 2019, Dornier MedTech announced the launch of its disposable, digital ureteroscope named Axis.
On the basis of product, the market is segmented into flexible ureteroscope and rigid ureteroscope. Among them, the flexible ureteroscope holds the largest market share of 89.5% and is also expected to grow with the fastest CAGR over the forecast period as it allows complete mobility of 180 degrees and also reduces the time frame of the hospital stays.
Based on the end-use, hospitals held a revenue share of 47.5% as patients majorly prefer hospitals for ureteroscopy procedures due to the presence of skilled healthcare professionals and favorable reimbursement policies. However, clinics are expected to show the fastest CAGR over the forecast period of 2022-2030.
North America dominated the market in 2021 and accounted for the largest revenue share of 41.7%. The growth of the segment can be attributed to the presence of a well-established healthcare system and the presence of key players within the region.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 241.8 million |
| Revenue Forecast by 2030 | USD 1.1586 billion |
| Growth rate from 2022 to 2030 | CAGR of 19.02% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Product, application, end-use, region |
| Companies Covered | Boston Scientific Corporation; Richard Wolf GmbH; Olympus Corporation; FUJIFILM Holdings Corporation; Karl Storz GmbH; Smith & Nephew Inc.; PENTAX Medical; Elmed Electronics & Medical Systems S.A.; Dornier MedTech; OPCOM; AED.MD |
Product Insights
On the basis of product, flexible ureteroscope holds the largest market share of 89.7% and is also expected to grow with the fastest CAGR over the forecast period. The past few years have witnessed huge improvements in terms of technology and clinical applications. Disposable flexible ureteroscope has undergone a series of advancement and thus, are widely used for diagnosis and therapeutic applications for multiple upper urinary tract pathologies. The flexible ureteroscope allows complete mobility of 180 degrees and also reduces the time frame of hospital stays.
Furthermore, the introduction of single-use digital flexible ureteroscope has opened new opportunities for the market as it provides detailed HD images for removing stones more efficiently and safely. Rigid ureteroscope is also expected to witness lucrative growth over the forecast period. Technological upgradation of rigid ureteroscope has reduced the sheath size of the caliber while providing a wide working channel. Although, a flexible ureteroscope permits high maneuverability but still provides a smaller working channel.
Application Insights
On the basis of application, urolithiasis holds the largest market share of 49.2% in the year 2021. The growth is majorly attributed to the worldwide prevalence of kidney stones. For instance, as per the article of Kidney International Org., kidney stones are a very common health disorder on the Western side of the world with a reported prevalence of 10-12% in men and 5-6% in women for a lifetime. Growing innovations and rapid adoption of advanced technology is expected to drive the market growth of this segment. Growing awareness of the disease among the patient population, presence of a large number of specialty clinics, and favorable government policies further drives the market growth.
However, others segment is expected to show the fastest CAGR growth of 21.4% over the forecast period. The growth can be attributed to rising cases of cancers such as urothelial carcinoma and urethral cancer. As per the article by the American Cancer Society, kidney cancer is among the most common type of cancer, and the penetration of kidney cancer among men is about 1 in 46 males, whereas, in women, it is about 1 in 80 females.
End-Use Insights
Based on the end-use the market is segmented into hospitals, clinics and diagnostic centers. Among them, hospitals hold the largest share of 47.92% as patients majorly prefer hospitals for ureteroscopy procedures due to the presence of skilled healthcare professionals and favorable reimbursement policies. Expansion of healthcare infrastructure, adoption of advanced technology, and worldwide increasing investment in the hospital sector further drive the market growth.
Growing cases of urolithiasis is positively impacting the market growth. For instance, as per the report of NCBI, about 9% of the U.S. population suffers from urinary stones every year. Increasing healthcare spending, rising trend of minimally invasive procedures, and advancement in the designing of products also contribute to the market growth of the segment.
However, clinics are expected to show the fastest CAGR growth of 19.5% over the forecast period of 2022-2030. The growth of the segment is attributed to a growing number of specialty clinics throughout the world and increasing healthcare spending in the private sector.
Regional Insights
North America dominated the market in 2021 and accounted for the largest revenue share of 41.88%. The growth of the market can be attributed to the presence of a highly-established healthcare system and the presence of key players within the region like Elmed Medical Systems, Boston Scientific, and Stryker. Other factors such as favorable reimbursement policies, patient awareness, and the adoption of advanced instruments are also supporting the market growth. Growing cases of pediatric stones in the region is also driving the market. As per the report of NIH, there has been a steep rise in the cases of kidney stones among young as well as adults in the U.S. due to increased salt intake, lowered fluid consumption, and obesity. Thus, further driving the market growth.
On the other hand, Asia Pacific is anticipated to register the fastest growth rate of 19.94% over the forthcoming years owing to the growing population, favorable government initiatives & support. Rising cases of kidney stones due to changes in climatic conditions and dietary habits boost the market expansion. For instance, according to NCBI, 1 in every 17 adults is affected by kidney stones in China. In addition, growing investment in the R&D sector, expansion of healthcare infrastructure, and the growing obese population is driving the market growth in the coming future.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Disposable Ureteroscope Market
5.1. COVID-19 Landscape: Disposable Ureteroscope Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Disposable Ureteroscope Market, By Product
8.1. Disposable Ureteroscope Market, by Product, 2022-2030
8.1.1 Flexible Ureteroscopes
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Rigid Ureteroscopes
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Disposable Ureteroscope Market, By Application
9.1. Disposable Ureteroscope Market, by Application, 2022-2030
9.1.1. Urolithiasis
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Urethral Stricture
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Kidney Cancer
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Disposable Ureteroscope Market, By End-Use
10.1. Disposable Ureteroscope Market, by End-Use, 2022-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Clinics
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Diagnostic Centers
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Disposable Ureteroscope Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-Use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 12. Company Profiles
12.1. Boston Scientific Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Richard Wolf GmbH
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Olympus Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. FUJIFILM Holdings Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Karl Storz GmbH
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Smith & Nephew Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. PENTAX Medical
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Elmed Electronics & Medical Systems S.A.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Dornier MedTech
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. OPCOM
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers